Yahoo
NasdaqCM - Delayed Quote USD

Aprea Therapeutics, Inc. (APRE)

0.4846 -0.0090 (-1.82%)
At close: October 30 at 4:00:01 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
13,223.0730
13,233.8360
14,319.6550
15,471.9630
37,372.0440
Operating Income
-13,223.0730
-13,233.8360
-14,319.6550
-15,471.9630
-37,372.0440
Net Non Operating Interest Income Expense
763.0400
652.0860
1,289.1440
1,224.1330
448.6670
Other Income Expense
152.7720
-17.8190
71.8000
-38.9260
-75,738.6500
Pretax Income
-12,307.2610
-12,599.5690
-12,958.7110
-14,286.7560
-112,662.0270
Net Income Common Stockholders
-12,307.2610
-12,599.5690
-12,958.7110
-14,286.7560
-112,662.0270
Diluted NI Available to Com Stockholders
-12,307.2610
-12,599.5690
-12,958.7110
-14,286.7560
-112,662.0270
Basic EPS
-0.94
-1.93
-2.35
-3.95
-67.99
Diluted EPS
-0.94
-1.93
-2.35
-3.95
-67.99
Basic Average Shares
20,615.1260
6,538.7220
5,509.9210
3,617.6070
1,657.0550
Diluted Average Shares
20,615.1260
6,538.7220
5,509.9210
3,617.6070
1,657.0550
Total Operating Income as Reported
-13,223.0730
-13,233.8360
-14,319.6550
-15,471.9630
-113,392.2280
Total Expenses
13,223.0730
13,233.8360
14,319.6550
15,471.9630
37,372.0440
Net Income from Continuing & Discontinued Operation
-12,307.2610
-12,599.5690
-12,958.7110
-14,286.7560
-112,662.0270
Normalized Income
-12,303.5330
-12,504.2500
-13,030.5110
-14,247.8300
-36,923.3770
Interest Income
763.0400
652.0860
1,289.1440
1,224.1330
448.6670
Net Interest Income
763.0400
652.0860
1,289.1440
1,224.1330
448.6670
EBIT
-13,223.0730
-13,233.8360
-14,319.6550
-15,471.9630
-37,372.0440
EBITDA
-13,201.0410
-13,212.1210
-14,297.3370
-15,464.9110
-37,185.5990
Reconciled Depreciation
22.0320
21.7150
22.3180
7.0520
186.4450
Net Income from Continuing Operation Net Minority Interest
-12,307.2610
-12,599.5690
-12,958.7110
-14,286.7560
-112,662.0270
Total Unusual Items Excluding Goodwill
-3.7280
-95.3190
71.8000
-38.9260
-75,738.6500
Total Unusual Items
-3.7280
-95.3190
71.8000
-38.9260
-75,738.6500
Normalized EBITDA
-13,197.3130
-13,116.8020
-14,369.1370
-15,425.9850
38,553.0510
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 10/3/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: